Latest News

GAO Report on Rebates in Medicare Part D Program

The United States GAO (General Accountability Office) released their report on Rebates in the Medicare Part D Program this month...

The Inflation Reduction Act of 2022...Winter is Coming

Looking ahead to 2025 for Part D benefits, things don’t look too rosy for health plans. The Inflation Reduction Act of 2022 will be...

It’s That Time Again: MTM Program Submission

2024 Submission The 2024 Medication Therapy Management Program (MTMP) submission date is June 7 and the MTMP attestations are due June...

Part D Benefit Administration Testing (BAT)

Part D Pharmacy Directors and Formulary administrators, Rebellis is ready to assist you with your 2023 BAT testing! Benefit...

What is your Medication Therapy Management Program really doing for your members?

Since the Comprehensive Medication Review (CMR) completion rate became a Star measure, Part D sponsors have devoted internal and vended...

2023 MA and Part D Final Rate Announcement Includes 8.5% Revenue Boost, Increased Star Ratings

The Centers for Medicare and Medicaid Services (CMS) published the Announcement of Calendar Year (CY) 2023 Medicare Advantage (MA)...

Have you Implemented and Tested the 2022 Audit Protocols?

Now that we are through the gates of AEP/OEP season, it’s time to focus on key upcoming events: Program Audits and Timeliness Monitoring...

Rethinking Formularies

The majority of Medicare Advantage Part D (MAPD) health plans utilize a “template formulary” configured by their PBM (Pharmacy Benefit...